- Research note
- Open Access
Detection of pandemic influenza A/H1N1/pdm09 virus among pigs but not in humans in slaughterhouses in Kenya, 2013–2014
BMC Research Notes volume 12, Article number: 628 (2019)
We conducted four cross-sectional studies over 1 year among humans and pigs in three slaughterhouses in Central and Western Kenya (> 350 km apart) to determine infection and exposure to influenza A viruses. Nasopharyngeal (NP) and oropharyngeal (OP) swabs were collected from participants who reported acute respiratory illness (ARI) defined as fever, cough or running nose. Nasal swabs and blood samples were collected from pigs. Human NP/OP and pig nasal swabs were tested for influenza A virus by real-time reverse transcriptase polymerase chain reaction (PCR) and pig serum was tested for anti-influenza A antibodies by ELISA.
A total of 288 participants were sampled, 91.3% of them being male. Fifteen (5.2%) participants had ARI but the nine swabs collected from them were negative for influenza A virus by PCR. Of the 1128 pigs sampled, five (0.4%) nasal swabs tested positive for influenza A/H1N1/pdm09 by PCR whereas 214 of 1082 (19.8%) serum samples tested for Influenza A virus antibodies. There was higher seroprevalence in colder months and among pigs reared as free-range. These findings indicate circulation of influenza A/H1N1/pdm09 among pigs perhaps associated with good adaptation of the virus to the pig population after initial transmission from humans to pigs.
Influenza A viruses circulate widely in animals, including birds, humans, pigs, and other mammals, and frequently cause severe epidemics and pandemics that affect both animals and humans [1,2,3,4]. The most recent influenza pandemic was in 2009, which was caused by a novel pig-origin influenza A virus resulting in > 500,000 human deaths globally . A common mechanism of emergence of novel influenza viruses is acquisition of new antigenic material during an inter-species transmission event [3, 6].
Pigs, long believed to be a mixing vessel for inter-species influenza virus transmission, can be a source of swine influenza infection to humans occupationally exposed to them . Pig slaughterhouses present a particularly prime environment for pig-to-human transmission of influenza A viruses, and with increasing pig farming in low biosafety and biosecurity settings in Kenya, the level of human exposures to swine influenza viruses has increased . Few studies on influenza virus transmission at the human-animal interface have been conducted in sub-Saharan Africa, including one in a Kenyan pig slaughterhouse that detected A/H1N1/pdm09 among pigs, suggesting introduction from humans .
To mitigate the severity of influenza pandemics, early detection through syndromic surveillance in humans is key . Even though human influenza surveillance in Kenya has improved by targeting acute respiratory illness at sentinel sites, there is no emphasis on people occupationally exposed to pigs or birds. Here, we conducted a series of cross-sectional studies among human and pigs in three pig slaughterhouses to determine infection and exposure to influenza A viruses.
We conducted four cross-sectional studies over a period of 1 year among humans and pigs in three slaughterhouses in Kiambu (Uthiru slaughterhouse), Kisumu and Siaya (Bondo slaughterhouse) counties (Fig. 1). Kiambu County in central Kenya features farms that have intensive pig production system while farms in Kisumu and Siaya counties in Western Kenya employ extensive pig production systems. These contrasting pig production systems represent varying degrees of contact between humans and pigs.
Sample size and sampling
All pig slaughterhouse workers, farmers and traders who visited the slaughterhouses to deliver pigs or to purchase meat, animal health personnel and others working in the slaughterhouses were requested to participate in the study. For pig sampling, an estimated seroprevalence of 20% was assumed, precision level of 5% and at 95% confidence level, giving a minimum sample size of 246 per sampling period. The slaughterhouses were visited each consecutive working day for 10 days to sample the pigs. For Uthiru (Kiambu) slaughterhouse, we sampled every other pig to a maximum of 25 per day. For Kisumu and Bondo (Siaya) slaughterhouse where volume of pigs slaughtered is low, all the pigs presented for slaughter on each day of sampling were targeted for sampling.
Human and animal sample collection
Nasopharyngeal (NP) and Oropharyngeal (OP) swabs were collected from participants reporting acute respiratory illness during sampling. Acute respiratory illness (ARI) was defined as reported cough, runny nose or sore throat. The swabs were placed in cryovials with virus transport medium (VTM) and shipped to Kenya Medical Research Institute (KEMRI) laboratories in Nairobi on ice, where they were preserved at − 80 °C until testing.
Nasal swabs and blood samples were collected from pigs; nasal swabs were placed in cryovials with VTM and shipped to KEMRI laboratories in Kisumu for storage at − 80 °C until testing. Blood samples were processed for sera on the same day of collection and stored at − 80 °C until testing. All testing of animal samples was at the KEMRI laboratories.
Serological and molecular testing for influenza A virus
We used IDEXX® ELISA kit (FlockChek AI MultiS-Screen Ab Test Kit®, Westbrook, Maine) to test animal serum for influenza A virus antibodies, following manufacturer instructions. We applied an adjusted cut-off of the S/N of < 0.673 for pig sera, which had been shown to increase sensitivity and specificity .
We used real-time reverse transcriptase polymerase chain reaction (RT-PCR) to test human NP/OP samples for influenza A virus RNA by applying primers and probes against the matrix gene of influenza A and NS1 gene of influenza B viruses . A cycle threshold (CT) value of ≤ 40 was the cut-off for positivity. Positive and negative controls were used to validate test assay.
Pig nasal swabs were tested for influenza A virus by RT-PCR using the CDC protocol for influenza A virus detection . The Influenza A sub-typing utilized oligonucleotides targeting hemagglutinin and neuraminidase genes (contemporary human pandemic H1, human AH3, AH7, AH5, N1 and N2) of swine influenza viruses .
Data collection and analysis
A structured questionnaire was administered to participants to collect data on sociodemographic characteristics, frequency and level of contact with pigs, influenza vaccination history and acute respiratory illness using Personal Digital Assistant devices running on a windows-based application. Data were cleaned and analyzed by the R statistical software . Descriptive statistics were conducted for socio-demographic characteristic by pig exposure status. Pig exposure was defined as any person who routinely skinned pigs, stunned pigs, sold pork or offals at the slaughterhouse. Categorical and continuous variables were compared using Chi Square test (or Fishers exact test) and Student t-test, respectively. Prevalence was determined as proportion of samples positive for influenza A virus against all samples tested.
The study was approved by the KEMRI Scientific and Ethical Review Committee and the Animal Care and Use Committee and all participants gave written informed consent before enrolment.
All three slaughterhouses operated for 5 days a week (Monday to Friday), receiving pigs from farms within the respective and neighboring counties. The Uthiru slaughterhouse received an average of 50 pigs per day while the Bondo and Kisumu slaughterhouses received 3 to 5 pigs per day. All pigs slaughtered in the three slaughterhouses were adults.
A total of 288 participants were sampled over the four sampling periods, 91 (31.6%) in September 2013, 43 (14.9%) in December 2013, 101 (35.1%) in May 2014, and 53 (18.4%) in September 2014. More than half (51.7%) of the participants were from Uthiru slaughterhouse.
Majority of participants were male (91.3%), and 35.4% (n = 102) of them were classified as pig exposed. The mean age for the participants was 35.5 years with a significant difference between the mean age of pig exposed (32.5 years) and non-pig exposed persons (37.2 years). Although 55.9% of all participants had completed at least secondary education, 5% of non-pig exposed had no formal education whereas all pig exposed participants had some formal education (Table 1).
Fifteen (5.2%) participants had ARI during the sampling periods. Of the 9 OP/NP swabs collected from these ARI cases, none were positive for influenza A virus.
In total, 1128 pigs were sampled (nasal swabs) for influenza testing, including 73% from Uthiru slaughterhouse. Of these, 5 pigs (0.4%) were positive for Influenza A virus RNA and all subtyped as A/H1N1/pdm09 virus. Serum was collected from 1082 pigs, 75% of them from Uthiru slaughterhouse. Of these, 214 (19.8%) pigs were positive for influenza A virus antibodies by ELISA. Samples collected in September 2014 had the highest prevalence of 37.1% (93 of 251), followed by September 2013 at 19.8% (47 of 237). Among the positive samples (n = 214), 65.4% (140) were collected in September 2013 or September 2014. Among slaughterhouses, 34.5% (30 of 87) of the samples from Bondo were seropositive, followed by 22.6% (21 of 93) in Kisumu slaughterhouse (Table 2). None of the farmers reported vaccinating their pigs against influenza.
We found evidence of both active influenza A virus infection and widespread exposure (seropositivity) among pigs but no infection among humans in a linked human-animal study in three slaughterhouses in Kenya. Influenza virus (A/H1N1/pdm09) virus RNA and antibodies, which is associated with seasonal human influenza in Kenya, was detected in the pig samples from central and western Kenya, suggesting either persistent human to pig transmission of influenza virus (A/H1N1/pdm09) or establishment and continued circulation of influenza virus (A/H1N1/pdm09) among pig populations . This finding is consistent with a similar study in Kenya where 0.5% of sampled pigs were found to have A/H1N1/pdm09 virus . Between 2016 and 2018 on average, seasonal human influenza in Kenya was associated with A/H1N1/pdm09 (32.5%), human A/H3N2 (33.8%) and influenza B (30.9%) .
Our study provides evidence of intense circulation of swine influenza virus among pig populations in two distinct geographical regions of Kenya, located > 350 kilometres apart, with the high average seroprevalence of 20%. The higher prevalence reported in Bondo (34.5%) and Kisumu (22.6%) slaughterhouses located in Western Kenya may be due to the free-range nature of pig production there, when compared with Uthiru slaughterhouse in the central region of the country where confined production system is practiced. Our findings also point to higher influenza transmission during the colder months (July–September) as supported by almost two-thirds of the seropositive pigs sampled during this period. In addition, all the PCR positive samples were collected during the cold season. Trends in human seasonal influenza in Kenya have also shown higher transmission during the colder months of June to August .
The occurrence of influenza A/H1N1/pdm09 virus in pigs has been documented in most regions of the world, including Africa where it has been reported in Kenya, Nigeria, Ghana and Cameroon [16, 18, 19]. Studies have shown that when influenza virus (A/H1N1/pdm09) circulates in local pig populations it continues to undergo antigenic changes over time . The influenza A virus seroprevalence reported in our study was comparable to 17% reported in an earlier study in Kenya . However, studies from other countries showed varied findings ranging from 5% in Uganda to 49% in Vietnam [21,22,23,24]. The variations in prevalence reported in the studies may be due to differences in sampling methodology (farm level vs live market vs slaughterhouses), and pig populations in the study area. The Southeast Asia region has large pig farms that likely support higher influenza virus transmission [23, 24].
In conclusion, our study reports detection of influenza virus (A/H1N1/pdm09) among pigs and high seroprevalence adding to the evidence of intense circulation among pigs from the few studies in the East Africa region. The increasing commercialization of pig farming in Kenya, provides a suitable environment for exposure and occurrence of zoonotic events related to influenza A virus . The evolution of reassortant viruses and their potential transmission to humans is unpredictable making routine monitoring at the pig-human interface a priority. Virological surveillance offers a mechanism to detect early any changes in the antigenic structure or zoonotic transmission events.
Limitations of the study
Our study had several limitations. We were not able to collect demographic data such as age, sex and farm level factors among the sampled pigs to allow for testing for associations with seropositivity. While most of the pigs brought for slaughter were mature adults, they were mostly delivered by traders who would not provide reliable farm level data on the sampled pigs. Another limitation is that we did not conduct haemagglutination inhibition (HI) tests to confirm the influenza strains circulating among pigs. However, another study in 2010–2012  reported 72% of seropositive pigs had influenza virus (A/H1N1/pdm09) by HI, findings which might reflect the diversity of influenza virus among pigs in our study.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
acute respiratory illness
Kenya Medical Research Institute
real-time reverse transcriptase polymerase chain reaction
virus transport medium
Reid AH, Taubenberger JK. The origin of the 1918 pandemic influenza virus: a continuing enigma. J Gen Virol. 2003;84:2285–92. http://europepmc.org/abstract/MED/12917448.
Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12:15–22. https://doi.org/10.3201/eid1201.050979.
Neumann G, Kawaoka Y. Predicting the Next Influenza Pandemics. J Infect Dis. 2019;219 (Supplement_1): S14–20. https://doi.org/10.1093/infdis/jiz040
Pan K. Understanding original antigenic sin in influenza with a dynamical system. PLoS ONE. 2011;6:e23910.
Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng P-Y, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12:687–95.
Rajao DS, Vincent AL, Perez DR. Adaptation of Human Influenza Viruses to Swine. Front Vet Sci. 2018;5:347.
Kumar B, Asha K, Khanna M, Ronsard L, Meseko CA, Sanicas M. The emerging influenza virus threat: status and new prospects for its therapy and control. Arch Virol. 2018;163:831–44.
Food and Agriculture Organization of the United Nations (FAO). Pig sector Kenya. Rome: Food and Agriculture Organization of the United Nations (FAO); 2012.
Munyua PM. Pandemic influenza virus in pigs raised in small holder farms in Kenya, 2010–2012. University of Nairobi; 2014. http://erepository.uonbi.ac.ke/handle/11295/78473.
Ciacci-Zanella JR, Vincent AL, Prickett JR, Zimmerman SM, Zimmerman JJ. Detection of anti-influenza a nucleoprotein antibodies in pigs using a commercial influenza epitope-blocking enzyme-linked immunosorbent assay developed for avian species. J Vet Diagn Investig. 2010;22:3–9.
Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol. 2002;40:3256–60.
Whiley DM, Bialasiewicz S, Bletchly C, Faux CE, Harrower B, Gould AR, et al. Detection of novel influenza A(H1N1) virus by real-time RT-PCR. J Clin Virol. 2009;45:203–4.
Richt JA, Lager KM, Clouser DF, Spackman E, Suarez DL, Yoon KJ. Real-time reverse transcription-polymerase chain reaction assays for the detection and differentiation of North American swine influenza viruses. J Vet Diagnostic Investig. 2004;16:367–73.
R Core Team. R Development Core Team. R: a language and environment for statistical computing. 2017;55:275–86. http://www.R-project.org.
Emukule GO, Mott JA, Spreeuwenberg P, Viboud C, Commanday A, Muthoka P, et al. Influenza activity in Kenya, 2007–2013: timing, association with climatic factors, and implications for vaccination campaigns. Influenza Other Respir Viruses. 2016;10:375–85.
Munyua P, Onyango C, Mwasi L, Waiboci LW, Arunga G, Fields B, et al. Identification and characterization of influenza A viruses in selected domestic animals in Kenya, 2010–2012. PLoS ONE. 2018;13:e0192721.
Kenya Ministry of Health. Kenya weekly influenza activity report. Nairobi: Kenya Ministry of Health; 2018.
Adeola OA, Olugasa BO, Emikpe BO. Detection of pandemic strain of influenza virus (A/H1N1/pdm09) in pigs, West Africa: implications and considerations for prevention of future influenza pandemics at the source. Infect Ecol Epidemiol. 2015;5:30227.
Njabo KY, Fuller TL, Chasar A, Pollinger JP, Cattoli G, Terregino C, et al. Pandemic A/H1N1/2009 influenza virus in Swine, Cameroon, 2010. Vet Microbiol. 2012;156:189–92.
Vincent A, Awada L, Brown I, Chen H, Claes F, Dauphin G, et al. Review of influenza A virus in swine worldwide: a call for increased surveillance and research. Zoonoses Public Health. 2014;61:4–17.
Kirunda H, Erima B, Tumushabe A, Kiconco J, Tugume T, Mulei S, et al. Prevalence of influenza A viruses in livestock and free-living waterfowl in Uganda. BMC Vet Res. 2014;10:50.
Baudon E, Peyre M, Peiris M, Cowling BJ. Epidemiological features of influenza circulation in swine populations: a systematic review and meta-analysis. PLoS ONE. 2017;12:e0179044.
Baudon E, Chu DKW, Tung DD, Thi Nga P, Vu Mai Phuong H, Le Khanh Hang N, et al. Swine influenza viruses in Northern Vietnam in 2013–2014. Emerg Microbes Infect. 2018;7:123.
Baudon E, Poon LL, Dao TD, Pham NT, Cowling BJ, Peyre M, et al. Detection of novel reassortant influenza A (H3N2) and H1N1 2009 pandemic viruses in swine in Hanoi. Vietnam: Zoonoses Public Health; 2015.
We thank the Ministry of Health, Ministry of Agriculture, and Fisheries, the County Governments of Kiambu, Kisumu and Siaya for providing administrative approval of the study. We appreciate the staff at the Kenya Medical Research Institute, Center for Global Health Research One Health program who conducted the field work. We also acknowledge Penina Munyua and Clayton Onyango from the Centers for Disease Control and Prevention-Kenya for their technical assistance during the implementation of the study.
The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the National Institute of Allergy and Infectious Diseases or US Centers for Disease Control and Prevention or the Government of Kenya.
This work was funded with funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services, Contract No. HHSN266200700007C and Core Funding of the Global Disease Detection Division of US Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Ethics approval and consent to participate
The study was approved by the KEMRI Scientific and Ethical Review Committee and the Animal Care and Use Committee and all participants gave written informed consent before enrolment. Written informed consent was also obtained from the animal owners for sampling of pigs and poultry.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.